跳至主要内容
临床试验/NL-OMON51744
NL-OMON51744尚未招募不适用

Perfusion monitoring in lower limbs of patients with peripheral arterial occlusive disease with continuous ICG video angiography - A pilot study - PERFUSE

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Written informed consent
  • - Rutherford class 4-6
  • - Occlusion at the level of the iliac or femoral arteries
  • - Unilateral disease. Control leg must have an ABI >= 0.8, no rest pain, and no

排除标准

  • - Insufficient knowledge of the Dutch language, illiteracy, or language barrier.
  • - Lower leg fracture within the past 12 months.
  • - (Partial) amputation of one of the feet and/or legs.
  • - Known hypersensitivity to indocyanine green or to sodium iodide.
  • - Hyper-thyroidism and autonomic thyroid adenomas.
  • - Renal insufficiency.
  • - Concomitant use of the following: anticonvulsants, bisulphite compounds,
  • haloperidol, heroin, meperidine, metamizole, methadone, morphium,
  • nitrofurantoin, opium alkaloids, phenobarbital, phenylbutazone, cyclopropane,
  • probenecid, and rifamycin.

研究者

相似试验